×
About 348 results

ALLMedicine™ Fungal Infections Center

Research & Reviews  130 results

Fungal infections in mechanically ventilated patients with COVID-19 during the first wa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626095
The Lancet. Respiratory Medicine; Gangneux JP, Dannaoui E et. al.

Nov 30th, 2021 - Patients with severe COVID-19 have emerged as a population at high risk of invasive fungal infections (IFIs). However, to our knowledge, the prevalence of IFIs has not yet been assessed in large populations of mechanically ventilated patients. We ...

Invasive aspergillosis of the skull base in an immunocompetent patient: a diagnostic ch...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593708
BMJ Case Reports; Borges A, Ferreira L et. al.

Nov 14th, 2021 - We describe the case of a 32-year-old man from Cape Verde having headache and increasing visual loss. Clinical and radiological investigations disclosed a massive destructive lesion involving the anterior and central skull base, orbit and nasoethm...

The association of cytomegalovirus infection and cytomegalovirus serostatus with invasi...
https://doi.org/10.1016/j.cmi.2021.10.008
Clinical Microbiology and Infection : the Official Public... Chuleerarux N, Nematollahi S et. al.

Nov 10th, 2021 - In allogeneic haematopoietic stem cell transplant (allo-HSCT) recipients, the inter-relationship between post-transplant cytomegalovirus (CMV) and subsequent invasive fungal infections (IFIs) is conflicting and the association of CMV serostatus wi...

Population pharmacokinetics of a posaconazole tablet formulation in transplant adult al...
https://doi.org/10.1016/j.ejps.2021.106049
European Journal of Pharmaceutical Sciences : Official Jo... Peña-Lorenzo D, Rebollo N et. al.

Oct 27th, 2021 - Posaconazole is an antifungal agent extensively used as a prophylaxis for invasive fungal infections (IFIs) in allogeneic stem cell transplant (SCT) recipients. Low posaconazole concentrations have been associated with reduced clinical response. T...

Population Pharmacokinetic Model-guided Optimization of Intravenous Voriconazole Dosing...
https://doi.org/10.1002/phar.2634
Pharmacotherapy Lin XB, Lui KY et. al.

Oct 17th, 2021 - This prospective study aimed to establish a population pharmacokinetic (PPK) model of intravenous voriconazole (VRC) in critically ill patients with liver dysfunction, and to explore the optimal dosing strategies in specific clinical scenarios for...

see more →

Guidelines  1 results

Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the...
https://doi.org/10.1093/annonc/mdr407
Annals of Oncology : Official Journal of the European Soc... Ruhnke M, Böhme A et. al.

Sep 29th, 2011 - Invasive fungal infections (IFIs) are a primary cause of morbidity and mortality in patients with hematological malignancies. Establishing a definite diagnosis of IFI in immunocompromised patients is particularly challenging and time consuming, bu...

see more →

Drugs  5 results see all →

News  3 results

American Thoracic Society Issues Guidelines on Treating Pulmonary Fungal Infections
https://www.staging.medscape.com/viewarticle/735650

Jan 12th, 2011 - January 12, 2011 — The American Thoracic Society (ATS) has issued updated clinical guidelines on treating pulmonary fungal infections, according to a statement published in the January 1, 2011, issue of the American Journal of Respiratory and Crit...

American Thoracic Society Issues Guidelines on Treating Pulmonary Fungal Infections
https://www.medscape.com/viewarticle/735650

Jan 12th, 2011 - January 12, 2011 — The American Thoracic Society (ATS) has issued updated clinical guidelines on treating pulmonary fungal infections, according to a statement published in the January 1, 2011, issue of the American Journal of Respiratory and Crit...

Mitigation of Human-Pathogenic Fungi That Exhibit Resistance to Medical Agents: Can Clinical Antifungal Stewardship Help?
https://www.medscape.com/viewarticle/825186_11

Future Perspective From a clinical perspective, the successful implementation of antifungal stewardship demands approaches that differ from those traditionally associated with antibiotic stewardship and the problem of drug-resistant bacteria – nam...

see more →